Acides benzoïques

<p>2-Bromo-5-hydroxybenzoic acid methyl ester (2BB) is a phenoxy activator that activates the glucokinase activator. It has been shown to have a glucose lowering effect in both animal and human studies. 2BB is orally bioavailable and has an allosteric mode of action, which means it works by binding to the allosteric site on the enzyme's active site, thereby increasing its activity. It binds to the benzamide of glucokinase, which causes an increase in glucose uptake and utilization by cells. 2BB is being studied for use as an oral treatment for type II diabetes mellitus.</p>

<p>4-Cyanobenzoic acid (4CB) is a benzene derivative that inhibits the activity of tyrosinase, an enzyme involved in the production of melanin. It is synthesized by reacting 2,4-dichlorobenzoic acid with sodium hydroxide and acetone. 4CB has been shown to have a potent inhibitory effect on the enzyme, with an isolated yield of up to 83%. The compound also shows strong hydrogen bonding interactions with water molecules and coordinates in a geometry where one of its oxygen atoms is double bonded to two nitrogen atoms. This structural analysis suggests that 4 CB may bind to tyrosinase through adsorption mechanism.</p>